The new field of epigenomics: Implications for cancer and other common disease research

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 69, Issue , 2004, Pages 447-456

  Bjornsson, H T ^a   Cui, H ^a   Gius, D ^b   Fallin, M D ^a   Feinberg, A P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 1; GENOMIC DNA; HISTONE; S ADENOSYLMETHIONINE; DNA METHYLTRANSFERASE 3B;

ACETYLATION; CANCER RESEARCH; CELL DIVISION; CELL MATURATION; COLORECTAL CANCER; CONFERENCE PAPER; CPG ISLAND; DNA METHYLATION; DNA REPLICATION; DNA SEQUENCE; EPIGENETICS; FLY; GENE EXPRESSION; GENE INTERACTION; GENE SEQUENCE; GENE SILENCING; GENETIC DISORDER; GENETIC VARIABILITY; GENOME ANALYSIS; GENOME IMPRINTING; GENOMICS; HUMAN; HYPOTHESIS; KNOCKOUT GENE; MALIGNANT NEOPLASTIC DISEASE; MATING TYPE; METASTASIS; NONHUMAN; PHOSPHORYLATION; POSITION EFFECT VARIEGATION; PRIORITY JOURNAL; PROTEIN BINDING; SEQUENCE ANALYSIS; SOMATIC CELL; TELOMERE; TESTIS CANCER; THEORETICAL STUDY; TRANSGENE; TUMOR SUPPRESSOR GENE; WART VIRUS; YEAST; ARTICLE; CANCER CELL; CHROMATIN STRUCTURE; DOWN REGULATION; ENVIRONMENTAL FACTOR; GENETIC RISK; GENETIC VARIATION; HEREDITARY TUMOR; MALIGNANT NEOPLASM; MALIGNANT TRANSFORMATION; MEDICAL RESEARCH; RARE DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

DOWN-REGULATION; EPIGENESIS, GENETIC; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENETIC DISEASES, INBORN; GENOMIC IMPRINTING; GENOMICS; HUMANS; MODELS, GENETIC; NEOPLASMS; UP-REGULATION;

HUMAN PAPILLOMAVIRUS TYPES;

EID: 23044463837     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2004.69.447     Document Type: Conference Paper

References (63)

1. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., and Zoghbi H.Y. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23: 185.
2. Bachman K.E., Park B.H., Rhee I., Rajagopalan H., Herman J.G., Baylin S.B., Kinzler K.W., and Vogelstein B. 2003. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 3: 89.
3. Bakin A.V. and Curran T. 1999. Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science 283: 387.
4. Bennett-Baker P.E., Wilkowski J., and Burke D.T. 2003. Age-associated activation of epigenetically repressed genes in the mouse. Genetics 165: 2055.
5. Bestor T.H. 2000. The DNA methyltransferases of mammals. Hum. Mol. Genet. 9: 2395.
6. Bird A.P. 1986. CpG-rich islands and the function of DNA methylation. Nature 321: 209.
7. Bjornsson H.T., Fallin M.D., and Feinberg A.P. 2004. An integrated epigenetic and genetic approach to common human disease. Trends Genet. 20: 350.
8. Brachmann C.B., Sherman J.M., Devine S.E., Cameron E.E., Pillus L., and Boeke J.D. 1995. The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability. Genes Dev. 9: 2888.
9. Cattanach B.M. and Beechey C.V. 1990. Autosomal and Xchromosome imprinting. Dev. Suppl. 1990: 63.
10. Chung J.H., Whiteley M., and Felsenfeld G. 1993. A 5′ element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell 74: 505.
11. Cooney C.A. 1993. Are somatic cells inherently deficient in methylation metabolism? A proposed mechanism for DNA methylation loss, senescence and aging. Growth Dev. Aging 57: 261.
12. Cui H., Horon I.L., Ohlsson R., Hamilton S.R., and Feinberg A.P. 1998. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat. Med. 4: 1276.
13. Cui H., Onyango P., Brandenburg S., Wu Y., Hsieh C.L., and Feinberg A.P. 2002. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res. 62: 6442.
14. Cui H., Cruz-Correa M., Giardiello F.M., Hutcheon D.F., Kafonek D.R., Brandenburg S., Wu Y., He X., Powe N.R., and Feinberg A.P. 2003. Loss of IGF2 imprinting: A potential marker of colorectal cancer risk. Science 299: 1753.
15. DeBaun M.R., Niemitz E.L., McNeil D.E., Brandenburg S.A., Lee M.P., and Feinberg A.P. 2002. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am. J. Hum. Genet. 70: 604.
16. de Koning D.J., Rattink A.P., Harlizius B., van Arendonk J.A., Brascamp E.W., and Groenen M.A. 2000. Genome-wide scan for body composition in pigs reveals important role of imprinting. Proc. Natl. Acad. Sci. 97: 7947.
17. Dorer D.R. and Henikoff S. 1994. Expansions of transgene repeats cause heterochromatin formation and gene silencing in Drosophila. Cell 77: 993.
18. Ehrlich M., Gama-Sosa M.A., Huang L.H., Midgett R.M., Kuo K.C., McCune R.A., and Gehrke C. 1982. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic Acids Res. 10: 2709.
19. Fedoriw A.M., Stein P., Svoboda P., Schultz R.M., and Bartolomei M.S. 2004. Transgenic RNAi reveals essential function for CTCF in H19 gene imprinting. Science 303: 238.
20. Feinberg A.P. and Tycko B. 2004. The history of cancer epigenetics. Nat. Rev. Cancer 4: 143.
21. Feinberg A.P. and Vogelstein B. 1983. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301: 89.
22. Feinberg A.P., Cui H., and Ohlsson R. 2002. DNA methylation and genomic imprinting: Insights from cancer into epigenetic mechanisms. Semin. Cancer Biol. 12: 389.
23. Gaudet F., Hodgson J.G., Eden A., Jackson-Grusby L., Dausman J., Gray J.W., Leonhardt H., and Jaenisch R. 2003. Induction of tumors in mice by genomic hypomethylation. Science 300: 489.
24. Gius D., Cui H., Bradbury C.M., Cook J., Smart D.K., Zhao S., Young L., Brandenburg S.A., Hu Y., Bisht K.S., Ho A.S., Mattson D., Sun L., Munson P.J., Chuang E.Y., Mitchell J.B., and Feinberg A.P. 2004. Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell 6: 361.
25. Gregory P.D. 2001. Transcription and chromatin converge: Lessons from yeast genetics. Curr. Opin. Genet. Dev. 11: 142.
26. Haber J.E. 1998. Mating-type gene switching in Saccharomyces cerevisiae. Annu. Rev. Genet. 32: 561.
27. Hendrich B. and Bickmore W. 2001. Human diseases with underlying defects in chromatin structure and modification. Hum. Mol. Genet. 10: 2233.
28. Holliday R. and Pugh J.E. 1975. DNA modification mechanisms and gene activity during development. Science 187: 226.
29. Huang C., Sloan E.A., and Boerkoel C.F. 2003. Chromatin remodeling and human disease. Curr. Opin. Genet. Dev. 13: 246.
30. Ingrosso D., Cimmino A., Perna A.F., Masella L., De Santo N.G., De Bonis M.L., Vacca M., D'Esposito M., D'Urso M., Galletti P., and Zappia V. 2003. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 361: 1693.
31. Jimenez-Sanchez G., Childs B., and Valle D. 2001. Human disease genes. Nature 409: 853.
32. Krawczak M., Ball E.V., and Cooper D.N. 1998. Neighboring-nucleotide effects on the rates of germ-line single-base-pair substitution in human genes. Am. J. Hum. Genet. 63: 474.
33. Ledbetter D.H. and Engel E. 1995. Uniparental disomy in humans: Development of an imprinting map and its implications for prenatal diagnosis. Hum. Mol. Genet. (Spec No.) 4: 1757.
34. Mackay D.J., Coupe A.M., Shield J.P., Storr J.N., Temple I.K., and Robinson D.O. 2002. Relaxation of imprinted expression of ZAC and HYMAI in a patient with transient neonatal diabetes mellitus. Hum. Genet. 110: 139.
35. Moore T. and Haig D. 1991. Genomic imprinting in mammalian development: A parental tug-of-war. Trends Genet. 7: 45.
36. Moulton T., Crenshaw T., Hao Y., Moosikasuwan J., Lin N., Dembitzer F., Hensle T., Weiss L., McMorrow L., Loew T., et al. 1994. Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nat. Genet. 7: 440.
37. Murata T., Kurokawa R., Krones A., Tatsumi K., Ishii M., Taki T., Masuno M., Ohashi H., Yanagisawa M., Rosenfeld M.G., Glass C.K., and Hayashi Y. 2001. Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome. Hum. Mol. Genet. 10: 1071.
38. Ogonuki N., Inoue K., Yamamoto Y., Noguchi Y., Tanemura K., Suzuki O., Nakayama H., Doi K., Ohtomo Y., Satoh M., Nishida A., and Ogura A. 2002. Early death of mice cloned from somatic cells. Nat. Genet. 30: 253.
39. Ohlsson R., Kanduri C., Whitehead J., Pfeifer S., Lobanenkov V., and Feinberg A.P. 2003. Epigenetic variability and the evolution of human cancer. Adv. Cancer Res. 88: 145.
40. Okamoto K., Morison I.M., Taniguchi T., and Reeve A.E. 1997. Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis. Proc. Natl. Acad. Sci. 94: 5367.
41. Ordway J.M., Williams K., and Curran T. 2004. Transcription repression in oncogenic transformation: Common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1. Oncogene 23: 3737.
42. Orlando V. 2003. Polycomb, epigenomes, and control of cell identity. Cell 112: 599.
43. Rainier S., Johnson L.A., Dobry C.J., Ping A.J., Grundy P.E., and Feinberg A.P. 1993. Relaxation of imprinted genes in human cancer. Nature 362: 747.
44. Reik W., Dean W., and Walter J. 2001. Epigenetic reprogramming in mammalian development. Science 293: 1089.
45. Rhee I., Jair K.W., Yen R.W., Lengauer C., Herman J.G., Kinzler K.W., Vogelstein B., Baylin S.B., and Schuebel K.E. 2000. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404: 1003.
46. Rhee I., Bachman K.E., Park B.H., Jair K.W., Yen R.W., Schuebel K.E., Cui H., Feinberg A.P., Lengauer C., Kinzler K.W., Baylin S.B., and Vogelstein B. 2002. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416: 552.
47. Riggs A.D. 1975. X inactivation, differentiation, and DNA methylation. Cytogenet. Cell Genet. 14: 9.
48. _. 1989. DNA methylation and cell memory. Cell Biophys. 15: 1.
49. Riggs A.D. and Pfeifer G.P. 1992. X-chromosome inactivation and cell memory. Trends Genet. 8: 169.
50. Sandovici I., Leppert M., Hawk P.R., Suarez A., Linares Y., and Sapienza C. 2003. Familial aggregation of abnormal methylation of parental alleles at the IGF2/H19 and IGF2R differentially methylated regions. Hum. Mol. Genet. 12: 1569.
51. Schoenherr C.J., Levorse J.M., and Tilghman S.M. 2003. CTCF maintains differential methylation at the Igf2/H19 locus. Nat. Genet. 33: 66.
52. Sollars V., Lu X., Xiao L., Wang X., Garfinkel M.D., and Ruden D.M. 2003. Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution. Nat. Genet. 33: 70.
53. Spielman R.S., McGinnis R.E., and Ewens W.J. 1993. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52: 506.
54. Statistics (National Center for Health Statistics). 2003. Health, United States, 2003. http://www.cdc.gov/nchs/hushtm.
55. Steenman M.J., Rainier S., Dobry C.J., Grundy P., Horon I.L., and Feinberg A.P. 1994. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nat. Genet. 7: 433.
56. Strahl B.D. and Allis C.D. 2000. The language of covalent histone modifications. Nature 403: 41.
57. Strichman-Almashanu L.Z., Lee R.S., Onyango P.O., Perlman E., Flam F., Frieman M.B., and Feinberg A.P. 2002. A genome-wide screen for normally methylated human CpG islands that can identify novel imprinted genes. Genome Res. 12: 543.
58. Tamashiro K.L., Wakayama T., Akutsu H., Yamazaki Y., Lachey J.L., Wortman M.D., Seeley R.J., D'Alessio D.A., Woods S.C., Yanagimachi R., and Sakai R.R. 2002. Cloned mice have an obese phenotype not transmitted to their offspring. Nat. Med. 8: 262.
59. Tartof K.D. and Bremer M. 1990. Mechanisms for the construction and developmental control of heterochromatin formation and imprinted chromosome domains. Dev. Suppl. 1990: 35-45.
60. van Overveld P.G., Lemmers R.J., Sandkuijl L.A., Enthoven L., Winokur S.T., Bakels F., Padberg G.W., van Ommen G.J., Frants R.R., and van der Maarel S.M. 2003. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat. Genet. 35: 315.
61. Varambally S., Dhanasekaran S.M., Zhou M., Barrette T.R., Kumar-Sinha C., Sanda M.G., Ghosh D., Pienta K.J., Sewalt R.G., Otte A.P., Rubin M.A., and Chinnaiyan A.M. 2002. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419: 624.
62. Woodson K., Flood A., Green L., Tangrea J.A., Hanson J., Cash B., Schatzkin A., and Schoenfeld P. 2004. Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women. J. Natl. Cancer Inst. 96: 407.
63. Xu G.L., Bestor T.H., Bourc'his D., Hsieh C.L., Tommerup N., Bugge M., Hulten M., Qu X., Russo J.J., and Viegas-Pequignot E. 1999. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402: 187.